Immunovant Inc (IMVT)

NASDAQ
14.36
-0.32(-2.18%)
After Hours
14.36
0.00(0.00%)
- Real-time Data
  • Volume:
    881,704
  • Day's Range:
    14.14 - 14.93
  • 52 wk Range:
    3.14 - 14.93
Trading near 52-week High

Immunovant has hit the highest price it has traded for over the last year (52 week period). This is a technical indicator that can be used to analyze the stock's current value and predict future price movement.

IMVT Overview

Prev. Close
14.68
Day's Range
14.14-14.93
Revenue
-
Open
14.79
52 wk Range
3.14-14.93
EPS
-1.52
Volume
881,704
Market Cap
1.86B
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
1,208,904
P/E Ratio
-8.73
Beta
1.26
1-Year Change
93.16%
Shares Outstanding
129,182,451
Next Earnings Date
Feb 03, 2023
What is your sentiment on Immunovant?
or
Market is currently closed. Voting is open during market hours.

Immunovant Inc News

Immunovant Inc Analysis

Immunovant Inc Company Profile

Immunovant Inc Company Profile

Employees
124

Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops batoclimab, a novel fully human monoclonal antibody that selectively binds to and inhibits the neonatal fragment crystallizable receptor, which is in Phase IIa clinical trials for the treatment of myasthenia gravis and thyroid eye disease, as well as completed initiation of Phase II clinical trials for the treatment of warm autoimmune hemolytic anemia. The company was incorporated in 2018 is headquartered in New York, New York. Immunovant, Inc. is a subsidiary of Roivant Sciences Ltd.

Read More

Analyst Price Target

Average13.00 (-9.47% Downside)
High30
Low4
Price14.36
No. of Analysts11
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Analysts 12-Month Price Target

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesBuyBuyBuyStrong BuyStrong Buy
Technical IndicatorsStrong BuySellSellStrong BuyStrong Buy
SummaryStrong BuyNeutralNeutralStrong BuyStrong Buy
  • hi
    0
    • https:/ ****benzinga.com/general/biotech/21/08/22272764/immunovant-stock-plunges-on-200m-equity-investment-from-roivant-to-support-imvt-1401-development
      0
      • WHY drop?
        0
        • 10 minuts and we already achieved average volume (3 months) a lot of fear and a lot of greed. Let's see who is right.
          0
          • I bought the dip yesterday at 10,00. Hope it recover soon
            0
            • people its literally on sale
              0
              • Bound to spike back up. It's the year of the bull.
                1
                • what happened?
                  0
                  • what happened?
                    0
                    • Chance of a bid 50:50?
                      0